I rate AbbVie stock as a Strong Buy, based on its FDA approval of Rinvoq. Read the latest analysis on the stock here.

This study highlights silicon nanostructures' potential in hydrogen generation and storage, addressing key challenges in the ...

When she was born, doctors informed Opal Sandy’s parents that their child would never hear. At the age of 11 months, she had ...

Two-thirds of Canadians (67 per cent, down three points) think sexual relations between an unmarried man and woman are ...

Lattice recently introduced its first family of ultra-secure FPGAs that support the full set of CNSA 2.0 cryptography ...

EMD Serono will sell fertility drugs on the Trump direct-to-consumer marketplace. Trump also preview plans to encourage ...

Nvidia's focus on sustainability puts the chipmaker ahead of its peers at a time when AI is driving record energy growth.

The Microscopic Artists Behind Pink Waters This is often caused by the presence of salt-tolerant algae that produces ...

Amgen and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic ...